| 中国 | トルコ | オーストリア | |
| 選択的アフェレーシス | ≈ $3,500 | ≈ $1,600 | ≈ $1,800 |
| 血漿交換術 | ≈ $2,200 | から $3,200 | ≈ $2,000 |
| 血漿交換 | ≈ $2,400 | ≈ $3,900 | ≈ $3,800 |
| 全身性エリテマトーデスの薬物療法 | ≈ $1,800 | ≈ $900 | ≈ $2,400 |
| クルクミン点滴 | ≈ $600 | ≈ $900 | ≈ $900 |
Bookimedはリウマチ科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。リウマチ科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。リウマチ科治療の旅路でお一人になることはありません。
Dr. Lin Shudian, MD, is Chief Physician and Director of Rheumatology and Immunology. He focuses on autoimmune diseases, especially inflammatory myopathies. He earned his MD in 2007 from Xiangya Hospital, Central South University. He completed advanced rheumatology training at Peking Union Medical College Hospital in 2015. He is Chairman of the Hainan Provincial Rheumatology Association. He is a committee member of the Rheumatology Branches of the Chinese Medical Association and the Chinese Medical Doctor Association. He is Deputy Director of the Hainan Provincial Medical Doctor Association Rheumatology Branch. He is an NSFC reviewer and serves on the editorial board of Hainan Medical Journal.
He has led three projects funded by the NSFC or Hainan Province. He has published more than 10 papers, including four indexed in SCI. He contributed to the translation of Kelley and Firestein’s Textbook of Rheumatology (8th–10th editions). He also helped compile Advanced Clinical Rheumatology, the 2020 China SLE Report, Comprehensive Rheumatology, and Liver-Related Rheumatic Diseases.